CULLEN/FROST BANKERS, INC. - VANECK VECTORS ETF TR ownership

VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 732 filers reported holding VANECK VECTORS ETF TR in Q1 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.6%.

Quarter-by-quarter ownership
CULLEN/FROST BANKERS, INC. ownership history of VANECK VECTORS ETF TR
ValueSharesWeighting
Q3 2023$132,693
+49.3%
4,931
+67.1%
0.00%0.0%
Q2 2023$88,855
-6.9%
2,9510.0%0.00%0.0%
Q1 2023$95,465
+12.9%
2,9510.0%0.00%0.0%
Q4 2022$84,576
+41.0%
2,951
+18.0%
0.00%
+100.0%
Q3 2022$60,000
-11.8%
2,5000.0%0.00%
-50.0%
Q2 2022$68,000
-29.2%
2,5000.0%0.00%0.0%
Q1 2022$96,000
+20.0%
2,5000.0%0.00%0.0%
Q4 2021$80,000
+8.1%
2,5000.0%0.00%
+100.0%
Q3 2021$74,000
+45.1%
2,500
+66.7%
0.00%0.0%
Q2 2021$51,000
+4.1%
1,5000.0%0.00%0.0%
Q1 2021$49,000
-9.3%
1,5000.0%0.00%0.0%
Q4 2020$54,000
-8.5%
1,5000.0%0.00%0.0%
Q3 2020$59,000
+7.3%
1,5000.0%0.00%0.0%
Q2 2020$55,000
+57.1%
1,5000.0%0.00%0.0%
Q1 2020$35,000
-20.5%
1,5000.0%0.00%0.0%
Q4 2019$44,000
+10.0%
1,5000.0%0.00%0.0%
Q3 2019$40,000
-44.4%
1,500
-46.4%
0.00%
-50.0%
Q2 2019$72,000
+14.3%
2,8000.0%0.00%0.0%
Q1 2019$63,0002,8000.00%
Other shareholders
VANECK VECTORS ETF TR shareholders Q1 2023
NameSharesValueWeighting ↓
New Harbor Financial Group, LLC 1,221,955$36,011,00014.81%
New Harbor Financial Group, LLC 1,155,900$34,064,00014.01%
Memorial Sloan Kettering Cancer Center 738,500$21,764,00013.56%
Hollow Brook Wealth Management LLC 670,275$19,753,00012.24%
Grand Central Investment Group 293,243$8,642,00011.46%
BW Gestao de Investimentos Ltda. 940,800$27,725,0008.44%
Slate Path Capital LP 5,930,000$174,757,0007.97%
Nokomis Capital, L.L.C. 512,628$15,107,0007.14%
Plaisance Capital LLC 288,000$8,487,0006.05%
Guild Investment Management, Inc. 200,114$5,897,0005.68%
View complete list of VANECK VECTORS ETF TR shareholders